(Updates to include BofA Securities commentary).
BofA Securities raised its price target on Johnson & Johnson (JNJ) to $278 from $263 ahead of the company's Q3 earnings report.
The brokerage increased its Icotyde forecasts and updated its model to reflect recent IPR&D. With limited script and sales data available, the brokerage made only minimal changes to its 2026 revenue estimates, analysts led by Jason Gerberry wrote in a Tuesday note.
Johnson & Johnson has an average rating of overweight and mean price target of $282.81, according to analysts polled by FactSet.
(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www.mtnewswires.com/contact-us)
Price: 265.90, Change: -6.05, Percent Change: -2.22